Featured Articles

  1. Making DCTs For Rare Disease Patients Commonplace 2/16/2022

    Learn about the importance of enhancing DCT design, planning, and implementation for rare disease patients to ensure they find answers to unlock that next gateway in their journey to health.

  2. Best Practices For Conducting Decentralized Clinical Trials In Japan 11/23/2021

    This webinar discusses decentralized clinical trials and the benefits they have proven for the clinical trial industry, specifically in Japan.

  3. What Can An Advanced Digital Platform Bring To Decentralized Clinical Trials? 10/28/2021

    In this video, Edward Triebell, Executive Director, Product Development of Digital Health, shares the key considerations around implementing technology and technological elements within clinical trials, recommendations on the best practices for integrating new systems and technologies, as well as what the future looks like when it comes to technology and decentralized trials.

  4. How To Build A Successful, Decentralized Clinical Trial And Avoid Common Mistakes 10/25/2021

    The process of decentralizing a clinical trial can be complicated, especially when the industry is accustomed to the “tried and true” approach. In this article, learn about the critical planning considerations needed to incorporate decentralization in your next trial.

  5. Decentralized Clinical Trials: How To Deliver The Complex Efficiently 8/10/2021

    Discover how with community based clinical trials, not only will patients find participation easier, but sites will see increased and faster recruitment rates, and sponsors will be able to recruit patients from wider geographical areas, leading to drugs entering the market quicker and more efficiently.

  6. Report: Impacts Of Decentralized Clinical Trials 2021 8/10/2021

    Decentralized clinical trials have had the potential to revolutionize studies for a number of years, though in the last two years, accelerated by COVID-19, they have finally started to realize some of that potential.  This final report based on 125 responses reveals unique insights into the adoption of decentralized trials today.

  7. Rare Hereditary Clinical Trial Case Study 8/10/2021

    Uncover how global home trial support visits aid research into a rare hereditary condition with a US-based pharmaceutical company specializing in RNA-targeted therapeutics.